iCAN Israel-Cannabis CEO Saul Kaye to Highlight Israel's Cannabis R&D Prowess at CWCBExpo

The Annual Cannabis World Congress & Business Exposition features the latest technologies, solutions and resources for cannabis-related companies

News provided by

iCAN- Israel Cannabis

30 Aug, 2016, 12:00 ET

TEL AVIV, Israel, August 30, 2016 /PRNewswire/ --

iCAN Israel-Cannabis CEO Saul Kaye will highlight Israel's world renowned expertise in cannabis R&D during his participation in the innovation panel at the upcoming Cannabis World Congress & Business Exposition in Los Angeles. The all-star panel entitled "CannaTech: How New Technology will Help Grow the Industry" will take place on Friday, September 9th at 3:00 pm.

Additional participants include Richard Gilchrist, Chief Revenue Officer at Guardian Data Systems, Ryan Smith - Co-Founder and CEO at LeafLink, and Todd Kleperis, VP Global Industry and Research at Broadband Discovery Systems.

"CWBCExpo serves as a unique bridge between the California and Israeli cannabis industries. I am excited to participate in this year's technology panel and strengthen the relationship between our two ecosystems," said Kaye, a pharmacist turned entrepreneur who is now a leader in developing and implementing growth opportunities in the burgeoning Israeli cannabis field.

"Israel's liberal policies concerning the use and research of medical cannabis coupled with our scientific, agricultural and technological prowess affords us the opportunity to lead and work together with a variety of businesses and organizations as cannabis policies evolve in the U.S. and globally."

The 3rd Annual Cannabis World Congress and Business Expo runs September 7-10 and is the leading forum for doing business in one of the fastest growing industries in the United States.

About iCAN Israel-Cannabis 

iCAN is a fast emerging Israeli private equity company focused on the cannabis space. iCAN was founded in 2015 by entrepreneurs who believe in the power of medical cannabis and the strength of Israeli research and innovation. iCAN is creating a portfolio of brands to strengthen the global cannabis industry. iCAN holds their annual flagship conference in Israel - CannaTech - the premier Cannabis conference showcasing Israeli technology and research to industry leaders.  CannaTech 2017 will take place March 20-22, 2017.

To interview Saul Kaye or for further information about iCAN: Israel-Cannabis contact [email protected].

SOURCE iCAN- Israel Cannabis

PRN Top Stories Newsletters

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Thank you for subscribing!

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.